Inhibitors of Discoidin Domain Receptor (DDR) Kinases for Cancer and Inflammation
The discoidin domain receptor tyrosine kinases DDR1 and DDR2 are distinguished from other kinase enzymes by their extracellular domains, which interact with collagen rather than with peptidic growth factors, before initiating signaling via tyrosine phosphorylation. They share significant sequence an...
Guardado en:
Autores principales: | William A. Denny, Jack U. Flanagan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3d373c76557544568673f60d030c67a7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Recent Progress in Development of Polo-Like Kinase 1 Inhibitors: Efforts So Far
por: Ramesh L. Sawant, et al.
Publicado: (2021) -
The Era of Janus Kinase Inhibitors for Inflammatory Bowel Disease Treatment
por: Jin-Woo Kim, et al.
Publicado: (2021) -
Small Molecule Inhibitors of MERTK and FLT3 Induce Cell Cycle Arrest in Human CD8<sup>+</sup> T Cells
por: Richard M. Powell, et al.
Publicado: (2021) -
Ahnung? Erkenntnis? Antizipatorisches in der DDR-Lyrik der Vor-Wende-Zeit
por: Peter Geist
Publicado: (2019) -
Globally Approved EGFR Inhibitors: Insights into Their Syntheses, Target Kinases, Biological Activities, Receptor Interactions, and Metabolism
por: Mohammed A. S. Abourehab, et al.
Publicado: (2021)